位置:首页 > 蛋白库 > L_ISFV
L_ISFV
ID   L_ISFV                  Reviewed;        2093 AA.
AC   Q5K2K3;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 1.
DT   03-AUG-2022, entry version 85.
DE   RecName: Full=RNA-directed RNA polymerase L;
DE            Short=Protein L;
DE   AltName: Full=Large structural protein;
DE   AltName: Full=Replicase;
DE   AltName: Full=Transcriptase;
DE   Includes:
DE     RecName: Full=RNA-directed RNA polymerase;
DE              EC=2.7.7.48 {ECO:0000250|UniProtKB:P03523};
DE   Includes:
DE     RecName: Full=GTP phosphohydrolase {ECO:0000250|UniProtKB:P28887};
DE              EC=3.6.1.- {ECO:0000250|UniProtKB:P28887};
DE   Includes:
DE     RecName: Full=GDP polyribonucleotidyltransferase;
DE              EC=2.7.7.88 {ECO:0000250|UniProtKB:P03523};
DE     AltName: Full=PRNTase {ECO:0000305};
DE   Includes:
DE     RecName: Full=mRNA cap methyltransferase {ECO:0000305};
DE              EC=2.1.1.375 {ECO:0000250|UniProtKB:P03523};
DE     AltName: Full=mRNA (guanine-N(7)-)-methyltransferase {ECO:0000250|UniProtKB:P03523};
DE              Short=G-N7-MTase {ECO:0000250|UniProtKB:P03523};
DE     AltName: Full=mRNA (nucleoside-2'-O-)-methyltransferase {ECO:0000250|UniProtKB:P03523};
DE              Short=N1-2'-O-MTase {ECO:0000250|UniProtKB:P03523};
GN   Name=L;
OS   Isfahan virus (ISFV).
OC   Viruses; Riboviria; Orthornavirae; Negarnaviricota; Haploviricotina;
OC   Monjiviricetes; Mononegavirales; Rhabdoviridae; Alpharhabdovirinae;
OC   Vesiculovirus.
OX   NCBI_TaxID=290008;
OH   NCBI_TaxID=10045; Gerbillinae (gerbils).
OH   NCBI_TaxID=9606; Homo sapiens (Human).
OH   NCBI_TaxID=29031; Phlebotomus papatasi (Sandfly).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=15614433; DOI=10.1007/s00705-004-0452-2;
RA   Marriott A.C.;
RT   "Complete genome sequences of Chandipura and Isfahan vesiculoviruses.";
RL   Arch. Virol. 150:671-680(2005).
CC   -!- FUNCTION: RNA-directed RNA polymerase that catalyzes the transcription
CC       of viral mRNAs, their capping and polyadenylation. The template is
CC       composed of the viral RNA tightly encapsidated by the nucleoprotein
CC       (N). The viral polymerase binds to the genomic RNA at the 3' leader
CC       promoter, and transcribes subsequently all viral mRNAs with a
CC       decreasing efficiency. The first gene is the most transcribed, and the
CC       last the least transcribed. The viral phosphoprotein acts as a
CC       processivity factor. Capping is concommitant with initiation of mRNA
CC       transcription. Indeed, a GDP polyribonucleotidyl transferase (PRNTase)
CC       adds the cap structure when the nascent RNA chain length has reached
CC       few nucleotides. Ribose 2'-O methylation of viral mRNA cap precedes and
CC       facilitates subsequent guanine-N-7 methylation, both activities being
CC       carried by the viral polymerase. Polyadenylation of mRNAs occur by a
CC       stuttering mechanism at a slipery stop site present at the end viral
CC       genes. After finishing transcription of a mRNA, the polymerase can
CC       resume transcription of the downstream gene.
CC       {ECO:0000250|UniProtKB:P03523}.
CC   -!- FUNCTION: RNA-directed RNA polymerase that catalyzes the replication of
CC       viral genomic RNA. The template is composed of the viral RNA tightly
CC       encapsidated by the nucleoprotein (N). The replicase mode is dependent
CC       on intracellular N protein concentration. In this mode, the polymerase
CC       replicates the whole viral genome without recognizing transcriptional
CC       signals, and the replicated genome is not caped or polyadenylated.
CC       {ECO:0000250|UniProtKB:P03523}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a ribonucleoside 5'-triphosphate + RNA(n) = diphosphate +
CC         RNA(n+1); Xref=Rhea:RHEA:21248, Rhea:RHEA-COMP:14527, Rhea:RHEA-
CC         COMP:17342, ChEBI:CHEBI:33019, ChEBI:CHEBI:61557, ChEBI:CHEBI:140395;
CC         EC=2.7.7.48; Evidence={ECO:0000255|PROSITE-ProRule:PRU00539};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GTP + H2O = GDP + H(+) + phosphate; Xref=Rhea:RHEA:19669,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58189;
CC         Evidence={ECO:0000250|UniProtKB:P28887};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 5'-end triphospho-adenylyl-adenylyl-cytidylyl-adenosine in
CC         mRNA + GDP + H(+) = a 5'-end (5'-triphosphoguanosine)-adenylyl-
CC         adenylyl-cytidylyl-adenosine in mRNA + diphosphate;
CC         Xref=Rhea:RHEA:65436, Rhea:RHEA-COMP:16797, Rhea:RHEA-COMP:16799,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, ChEBI:CHEBI:58189,
CC         ChEBI:CHEBI:156484, ChEBI:CHEBI:156503; EC=2.7.7.88;
CC         Evidence={ECO:0000250|UniProtKB:P28887};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 5'-end (5'-triphosphoguanosine)-adenylyl-adenylyl-cytidylyl-
CC         adenosine in mRNA + 2 S-adenosyl-L-methionine = a 5'-end (N(7)-methyl
CC         5'-triphosphoguanosine)-(2'-O-methyladenylyl)-adenylyl-cytidylyl-
CC         adenosine in mRNA + H(+) + 2 S-adenosyl-L-homocysteine;
CC         Xref=Rhea:RHEA:65376, Rhea:RHEA-COMP:16797, Rhea:RHEA-COMP:16798,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789,
CC         ChEBI:CHEBI:156483, ChEBI:CHEBI:156484; EC=2.1.1.375;
CC         Evidence={ECO:0000250|UniProtKB:P03523};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 5'-end (5'-triphosphoguanosine)-adenylyl-adenylyl-cytidylyl-
CC         adenosine in mRNA + S-adenosyl-L-methionine = a 5'-end (5'-
CC         triphosphoguanosine)-(2'-O-methyladenylyl)-adenylyl-cytidylyl-
CC         adenosine in mRNA + H(+) + S-adenosyl-L-homocysteine;
CC         Xref=Rhea:RHEA:65380, Rhea:RHEA-COMP:16797, Rhea:RHEA-COMP:16801,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789,
CC         ChEBI:CHEBI:156482, ChEBI:CHEBI:156484;
CC         Evidence={ECO:0000250|UniProtKB:P03523};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 5'-end (5'-triphosphoguanosine)-(2'-O-methyladenylyl)-
CC         adenylyl-cytidylyl-adenosine in mRNA + S-adenosyl-L-methionine = a
CC         5'-end (N(7)-methyl 5'-triphosphoguanosine)-(2'-O-methyladenylyl)-
CC         adenylyl-cytidylyl-adenosine in mRNA + S-adenosyl-L-homocysteine;
CC         Xref=Rhea:RHEA:65440, Rhea:RHEA-COMP:16798, Rhea:RHEA-COMP:16801,
CC         ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:156482,
CC         ChEBI:CHEBI:156483; Evidence={ECO:0000250|UniProtKB:P03523};
CC   -!- SUBUNIT: May form homodimer. Interacts with the P protein.
CC       {ECO:0000250|UniProtKB:P03523}.
CC   -!- SUBCELLULAR LOCATION: Virion {ECO:0000250|UniProtKB:P03523}. Host
CC       cytoplasm {ECO:0000250|UniProtKB:P03523}. Note=L and P are packaged
CC       asymmetrically towards the blunt end of the virus.
CC       {ECO:0000250|UniProtKB:P03523}.
CC   -!- SIMILARITY: Belongs to the rhabdoviridae protein L family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ810084; CAH17548.1; -; Genomic_RNA.
DR   RefSeq; YP_007641386.1; NC_020806.1.
DR   SMR; Q5K2K3; -.
DR   PRIDE; Q5K2K3; -.
DR   GeneID; 14857914; -.
DR   KEGG; vg:14857914; -.
DR   Proteomes; UP000204017; Genome.
DR   GO; GO:0030430; C:host cell cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; IEA:RHEA.
DR   GO; GO:0004482; F:mRNA (guanine-N7-)-methyltransferase activity; IEA:InterPro.
DR   GO; GO:0003968; F:RNA-directed 5'-3' RNA polymerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0039689; P:negative stranded viral RNA replication; ISS:UniProtKB.
DR   Gene3D; 3.40.50.150; -; 1.
DR   InterPro; IPR039530; L_methyltransferase_rhabdo.
DR   InterPro; IPR039736; L_poly_C.
DR   InterPro; IPR026890; Mononeg_mRNAcap.
DR   InterPro; IPR014023; Mononeg_RNA_pol_cat.
DR   InterPro; IPR025786; Mononega_L_MeTrfase.
DR   InterPro; IPR017234; RNA-dir_pol_rhabdovirus.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   Pfam; PF14314; Methyltrans_Mon; 1.
DR   Pfam; PF14318; Mononeg_mRNAcap; 1.
DR   Pfam; PF00946; Mononeg_RNA_pol; 1.
DR   PIRSF; PIRSF037546; RNA_pol_RhabdoV_sub; 1.
DR   TIGRFAMs; TIGR04198; paramyx_RNAcap; 1.
DR   PROSITE; PS50526; RDRP_SSRNA_NEG_NONSEG; 1.
DR   PROSITE; PS51590; SAM_MT_MNV_L; 1.
PE   3: Inferred from homology;
KW   ATP-binding; Host cytoplasm; Hydrolase; Methyltransferase; mRNA capping;
KW   mRNA processing; Multifunctional enzyme; Nucleotide-binding;
KW   Nucleotidyltransferase; RNA-directed RNA polymerase;
KW   S-adenosyl-L-methionine; Transferase; Viral RNA replication; Virion.
FT   CHAIN           1..2093
FT                   /note="RNA-directed RNA polymerase L"
FT                   /id="PRO_0000287260"
FT   DOMAIN          587..773
FT                   /note="RdRp catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00539"
FT   DOMAIN          1629..1826
FT                   /note="Mononegavirus-type SAM-dependent 2'-O-MTase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00923"
FT   REGION          1..23
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         1656..1665
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   2093 AA;  237644 MW;  B65373A9AB43E2C9 CRC64;
     MDEYSEEKWG DSDEESFGTG KYSDESRIRG LNSVDYNLNS PLIQDDLYYL MERVRGRPVP
     PIWKAKNWTE TIHLVQESRL DYLPTQKLHS WYAEWLMEES HDSSQGLAFL KEVDKDSLET
     YEVVMSFLRG WCGGAPAYKK KEGRHIAKIG SLCQKFLDLH RVILIMNAST QMELSNLAET
     FQASSVSKKI ITTPSMGKME MSGQFALAYQ QKVILDRNFL LMMKDVVIGR MQTLLSMVSR
     TDDKFSDGDI SYLIKIYQLG DKIIQSLGND GYELIKTIEP MCNLRLSDLA REYRPLIPEF
     PHFRQHIEGT VSELRKKTAL IVDMFKMIDR TPGVDITLVI YGSFRHWGHP FIDYFAGLTK
     LNSQVTMGKQ IDDEYVACLA SDLARIVLTK EFNEKKRWSV NYNLVPQDHP FHEHIRDNTW
     PTPAVIQDFG DKWHELPLTQ CFEIPDLIDP SIIYSDKSHS MNRQDVLNHV KRKPDQPIPS
     RKVLQTMIDT PATNWLEFLE EIDKNGLSDD DLVIGLKGKE RELKIAGRFF SLMSWKLREY
     FVITEYLIKT HFVPLFHGLT MADDMTAVIK KMLESSSGQG LKDYSAVCIA NHIDYEKWNN
     HQRKRSNEPI FKVMGQFLGF PNLISRTHEF FEKSLIYYNG RPDLMKVQDG RLVNTTKQLV
     CWEGQAGGLE GLRQKGWSIL NLLVIQRESK IRNTAVKVLA QGDNQVICTQ YKTKQHRNET
     ELRSALTQMK LNNDAVMKAI ESGTNKLGLL INQDETMQSA DYLNYGKVPI FRGVIRGLET
     KRWSRVTCVT NDQLPTCANL MSSVSTNALT VAHFDVTPLN AMIQYNYFGN FSRLLLNMHD
     PAVRCSLFQL SQKHKIDLFS FEFKVGVLYL DPSIGGVCGT ALSRFLIRGF PDPVTESISF
     WKVIYNNTQD NRLKKLCTAF GNPKIAQFRY SHIEKLLEDP TSLNISMGMS AANLLKSEIK
     KNLLRKRRTI GNSIVRDAVT YIHSEDEKIR SYLWSINPLF PRFLSEFKSG TFMGVASSVV
     SLFQNSRTIR NVFKDYMSSA IDELITKSEV NSLEHLCKYK GVRNFDQVWK CSASQADYLR
     RLSWGRKVLG TTIPHPLEML GAGTIKNNSS TCCEHSGQDY ISVFCPKGIS NVLIERGPMA
     AYLGSKTSES TSILQPWEKE SKIPIIKRAT RLRDAIHWFV EPSSNLAKSI LQNITALTGE
     EWGSSLEGFK RTGSALHRFT TSRMSHGGFC AQSPAALTRM MATTDTMSDY AKDNYDFMFQ
     ACLLFSQITT SVLLLETTIS NTVHFHTRCI NCVRKIEEPW LESPSVLQSK DVSNVLASWR
     NGGGSWGEQL HQLKPLKGDW EILTPAEKSY HVGRTLGFLF GDLTGQSSIR ADDSSLFPLS
     IQKRLRGRGF LRGVLDGLVR ASACQVIHRR SLTQLKRPAN AVYGGLIFLI DKISASSTFI
     NLCRDGPIRE ELSSIPHKIP TSYPTSNADL GLHIRNYFKF QCKSVELGKY QSDLEDLWLF
     SDLLSSGFAG PYALSSKVLK SLYKPSLSRR DRNNIRKLGA LSRLLRSHEN WSELHKEFLT
     SQLLLCQEEV RHACKFGIPK NVSAKSSMVW GKEAVSYVLD IPVEFTSQKQ TKHLNACPRI
     QDPTISGLRL GQLPTGAHYK IRTILNAYNI KCRDVLCGGD GSGGMTAACL RYYSNSRAIF
     NSILEFDGSS MKGSSPDPPS ALETVDQGMV RCVNATTCWE NPSDLSQERT WDYFLHLKKS
     FNMKIDLIIL DMEVRDFQIS KLIEGNLRLK ISKLLEKNGT LIYKTYGTII CSETSNVLTT
     LGPLFHSVYI VQTGYSSSFT SEVYVLFSKQ KSFVDSPYVD WGSLQYNWEK LACFRNPRQE
     FKRALRIRSS RSLMGIPSSF LPDPLVNLET LLQISGVPSG VSHQLVTDVK SSGASGLSSA
     IGLLGLISHF TLDVTKLYVQ EYRPPSDNRL IKMASAITGI SYWISIAYHD QQLNQALTSV
     IKKSFPIRWG LINHRLHWSV SDRFHRSKDV RLSDCLAGIG NWIRGMELMK LPAGMFSHKE
     VNMILSKYIR GLNYHTISSR TGILEILKSQ FSIIDRSLMT ITTDNIQSSD WTD
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024